| Year |
Citation |
Score |
| 2025 |
Young JS, Cho NW, Lucas CG, Najem H, Mirchia K, Chen WC, Seo K, Zakimi N, Daggubati V, Casey-Clyde T, Nguyen MP, Chen A, Phillips JJ, Ozawa T, Aghi MK, ... ... Raleigh DR, et al. IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma. Biorxiv : the Preprint Server For Biology. PMID 40161763 DOI: 10.1101/2025.03.12.642800 |
0.365 |
|
| 2025 |
Lin K, Zou C, Hubbard A, Sengelmann S, Goudy L, Wang IC, Sharma R, Pak J, Foster K, Ozawa T, de Groot JF, Phillips J, Vasudevan HN, Raleigh DR, Marson A, et al. Multiplexed epigenetic memory editing using CRISPRoff sensitizes glioblastoma to chemotherapy. Neuro-Oncology. PMID 39998382 DOI: 10.1093/neuonc/noaf055 |
0.357 |
|
| 2025 |
Morshed RA, Nguyen MP, Choudhury A, Al-Adli NN, Magill ST, Haddad AF, Mirchia K, Lucas CG, Theodosopoulos PV, McDermott MW, Chen WC, Raleigh DR. The Impact of MRI-Defined Extent of Resection Across Meningioma DNA Methylation Groups: Re-Evaluating Surgery in the Era of Meningioma Molecular Classification. Neurosurgery. PMID 39773932 DOI: 10.1227/neu.0000000000003324 |
0.523 |
|
| 2024 |
Lucas CG, Al-Adli NN, Young JS, Gupta R, Morshed RA, Wu J, Ravindranathan A, Shai A, Oberheim Bush NA, Taylor JW, de Groot J, Villanueva-Meyer JE, Pekmezci M, Perry A, Bollen AW, ... ... Raleigh DR, et al. Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses. Neuro-Oncology. PMID 39560080 DOI: 10.1093/neuonc/noae214 |
0.534 |
|
| 2024 |
Liu SJ, Zou C, Pak J, Morse A, Pang D, Casey-Clyde T, Borah AA, Wu D, Seo K, O'Loughlin T, Lim DA, Ozawa T, Berger MS, Kamber RA, Weiss WA, ... Raleigh DR, et al. In vivo perturb-seq of cancer and microenvironment cells dissects oncologic drivers and radiotherapy responses in glioblastoma. Genome Biology. 25: 256. PMID 39375777 DOI: 10.1186/s13059-024-03404-6 |
0.353 |
|
| 2024 |
Nguyen MP, Morshed RA, Youngblood MW, Perlow HK, Lucas CG, Patel AJ, Palmer JD, Horbinski CM, Magill ST, Chen WC, Raleigh DR. A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence. Neuro-Oncology. PMID 39340366 DOI: 10.1093/neuonc/noae198 |
0.521 |
|
| 2024 |
Eaton CD, Avalos L, Liu SJ, Chen Z, Zakimi N, Casey-Clyde T, Bisignano P, Lucas CG, Stevenson E, Choudhury A, Vasudevan HN, Magill ST, Young JS, Krogan NJ, Villanueva-Meyer JE, ... ... Raleigh DR, et al. Merlin phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features. Nature Communications. 15: 7873. PMID 39251601 DOI: 10.1038/s41467-024-52284-8 |
0.541 |
|
| 2024 |
Morshed RA, Nguyen MP, Youngblood MW, Perlow HK, Lucas CG, Patel AJ, Palmer JD, Chandler JP, Theodosopoulos PV, Magill ST, Chen WC, Raleigh DR. Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma. Neurosurgery. PMID 39101743 DOI: 10.1227/neu.0000000000003133 |
0.538 |
|
| 2024 |
Leclair NK, Choudury A, Chen WC, Magill ST, McCortney K, Horbinski CM, Chen Z, Goldschmidt E, Eaton CD, Bulsara KR, Linda Bi W, Patel AJ, Sahm F, Raleigh D, Anczukow O. RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups. Neuro-Oncology. PMID 39093629 DOI: 10.1093/neuonc/noae150 |
0.541 |
|
| 2024 |
Umbach G, Kanungo I, Quintana D, Choudhury A, Morshed R, Villanueva-Meyer J, Theodosopoulos P, Magill ST, McDermott M, Raleigh D, Goldschmidt E. Calcified meningiomas demonstrate equivocal grade, proliferation, and immediate surgical outcomes. World Neurosurgery. PMID 38936608 DOI: 10.1016/j.wneu.2024.06.120 |
0.518 |
|
| 2024 |
Shetty A, Wang S, Khan AB, English CW, Nouri SH, Magill ST, Raleigh DR, Klisch TJ, Harmanci AO, Patel AJ, Harmanci AS. Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data. Journal of Neuro-Oncology. PMID 38834749 DOI: 10.1007/s11060-024-04731-1 |
0.508 |
|
| 2024 |
Shetty A, Wang S, Khan AB, English CW, Nouri SH, Magill ST, Raleigh DR, Klisch TJ, Harmanci AO, Patel AJ, Harmanci AS. Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data. Journal of Neuro-Oncology. PMID 38811523 DOI: 10.1007/s11060-024-04710-6 |
0.504 |
|
| 2024 |
Lucas CG, Mirchia K, Seo K, Najem H, Chen WC, Zakimi N, Foster K, Eaton CD, Cady MA, Choudhury A, Liu SJ, Phillips JJ, Magill ST, Horbinski CM, Solomon DA, ... ... Raleigh DR, et al. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution. Nature Genetics. PMID 38760638 DOI: 10.1038/s41588-024-01747-1 |
0.555 |
|
| 2024 |
Choudhury A, Cady MA, Lucas CG, Najem H, Phillips JJ, Palikuqi B, Zakimi N, Joseph T, Birrueta JO, Chen WC, Oberheim Bush NA, Hervey-Jumper SL, Klein OD, Toedebusch CM, Horbinski CM, ... ... Raleigh DR, et al. Perivascular NOTCH3+ stem cells drive meningioma tumorigenesis and resistance to radiotherapy. Cancer Discovery. PMID 38742767 DOI: 10.1158/2159-8290.CD-23-1459 |
0.563 |
|
| 2024 |
Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC, Foster K, Chen WC, Villanueva-Meyer JE, Swaney DL, Vasudevan HN, Choudhury A, Pak J, Breshears JD, Lang UE, ... ... Raleigh DR, et al. Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nature Communications. 15: 476. PMID 38216587 DOI: 10.1038/s41467-023-40408-5 |
0.609 |
|
| 2024 |
Vasudevan HN, Payne E, Delley CL, John Liu S, Mirchia K, Sale MJ, Lastella S, Nunez MS, Lucas CG, Eaton CD, Casey-Clyde T, Magill ST, Chen WC, Braunstein SE, Perry A, ... ... Raleigh DR, et al. Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance. Nature Communications. 15: 477. PMID 38216572 DOI: 10.1038/s41467-024-44755-9 |
0.55 |
|
| 2024 |
Umbach G, Tran EB, Eaton CD, Choudhury A, Morshed R, Villanueva-Meyer JE, Theodosopoulos PV, Magill ST, McDermott MW, Raleigh DR, Goldschmidt E. Epidemiology, Genetics, and DNA Methylation Grouping of Hyperostotic Meningiomas. Operative Neurosurgery (Hagerstown, Md.). PMID 38189372 DOI: 10.1227/ons.0000000000001052 |
0.548 |
|
| 2023 |
Hadad S, Gupta R, Oberheim Bush NA, Taylor JW, Villanueva-Meyer JE, Young JS, Wu J, Ravindranathan A, Zhang Y, Warrier G, McCoy L, Shai A, Pekmezci M, Perry A, Bollen AW, ... ... Raleigh DR, et al. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Acta Neuropathologica. 147: 3. PMID 38079020 DOI: 10.1007/s00401-023-02654-1 |
0.539 |
|
| 2023 |
Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci A, Klisch TJ, Nguyen MP, Vasudevan HN, ... ... Raleigh DR, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Nature Medicine. PMID 37944590 DOI: 10.1038/s41591-023-02586-z |
0.624 |
|
| 2023 |
Chen WC, Lucas CG, Magill ST, Rogers CL, Raleigh DR. Radiotherapy and radiosurgery for meningiomas. Neuro-Oncology Advances. 5: i67-i83. PMID 37711972 DOI: 10.1093/noajnl/vdac088 |
0.558 |
|
| 2023 |
Choudhury A, Cady MA, Lucas CG, Najem H, Phillips JJ, Palikuqi B, Zakimi N, Joseph T, Birrueta JO, Chen WC, Bush NAO, Hervey-Jumper SL, Klein OD, Toedebusch CM, Horbinski CM, ... ... Raleigh DR, et al. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy. Biorxiv : the Preprint Server For Biology. PMID 37503127 DOI: 10.1101/2023.07.10.548456 |
0.561 |
|
| 2023 |
Nandoliya KR, Sadagopan NS, Thirunavu V, Houskamp EJ, Karras CL, Chaliparambil RK, Sriram N, Jamshidi P, Raleigh DR, Lukas RV, Magill ST. Post-Surgical Prognosis of Patients with Pineoblastoma: A Systematic Review and Individual Patient Data Analysis with Trends over Time. Cancers. 15. PMID 37444483 DOI: 10.3390/cancers15133374 |
0.559 |
|
| 2023 |
Lucas CH, Mirchia K, Seo K, Najem H, Chen W, Zakimi N, Choudhury A, Liu SJ, Phillips J, Magill S, Horbinski C, Solomon D, Perry A, Vasudevan H, Heimberger A, ... Raleigh D, et al. Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution. Research Square. PMID 37292686 DOI: 10.21203/rs.3.rs-2921804/v1 |
0.574 |
|
| 2023 |
Raleigh D, Chen W, Choudhury A, Youngblood M, Polley MY, Lucas CH, Mirchia K, Maas S, Suwala A, Won M, Bayley J, Harmanci A, Harmanci A, Klisch T, Nguyen M, et al. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses. Research Square. PMID 36993741 DOI: 10.21203/rs.3.rs-2663611/v1 |
0.629 |
|
| 2023 |
Eaton C, Avalos L, Liu SJ, Casey-Clyde T, Bisignano P, Lucas CH, Stevenson E, Choudhury A, Vasudevan H, Magill S, Krogan N, Villanueva-Meyer J, Swaney D, Raleigh D. MerlinS13 phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features. Research Square. PMID 36993679 DOI: 10.21203/rs.3.rs-2577844/v1 |
0.57 |
|
| 2023 |
Khan AB, English CW, Chen WC, Athukuri P, Bayley JC, Brandt VL, Shetty A, Hadley CC, Choudhury A, Lu HC, Harmanci AO, Harmanci AS, Magill ST, Raleigh DR, Klisch TJ, et al. Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. Acta Neuropathologica. PMID 36729132 DOI: 10.1007/s00401-023-02543-7 |
0.485 |
|
| 2022 |
Chen WC, Perlow HK, Choudhury A, Nguyen MP, Mirchia K, Youngblood MW, Lucas CG, Palmer JD, Magill ST, Raleigh DR. Radiotherapy for meningiomas. Journal of Neuro-Oncology. PMID 36315366 DOI: 10.1007/s11060-022-04171-9 |
0.569 |
|
| 2022 |
Nguyen MP, Morshed RA, Dalle Ore CL, Cummins DD, Saggi S, Chen WC, Choudhury A, Ravi A, Raleigh DR, Magill ST, McDermott MW, Theodosopoulos PV. Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma. Journal of Neurosurgery. 1-9. PMID 36303473 DOI: 10.3171/2022.4.JNS212516 |
0.561 |
|
| 2022 |
Choudhury A, Chen WC, Lucas CG, Bayley JC, Harmanci AS, Maas SLN, Santagata S, Klisch T, Perry A, Bi WL, Sahm F, Patel A, Magill ST, Raleigh DR. Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features. Neuro-Oncology. PMID 36227281 DOI: 10.1093/neuonc/noac224 |
0.533 |
|
| 2022 |
Lucas CG, Sloan EA, Gupta R, Wu J, Pratt D, Vasudevan HN, Ravindranathan A, Barreto J, Williams EA, Shai A, Whipple NS, Bruggers CS, Maher O, Nabors B, Rodriguez M, ... ... Raleigh DR, et al. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. Acta Neuropathologica. PMID 35945463 DOI: 10.1007/s00401-022-02478-5 |
0.573 |
|
| 2022 |
Gleason JM, Klass SH, Huang P, Ozawa T, Santos RA, Fogarty MM, Raleigh DR, Berger MS, Francis MB. Intrinsically Disordered Protein Micelles as Vehicles for Convection-Enhanced Drug Delivery to Glioblastoma Multiforme. Acs Applied Bio Materials. PMID 35857070 DOI: 10.1021/acsabm.2c00215 |
0.344 |
|
| 2022 |
Vasudevan HN, Choudhury A, Hilz S, Villanueva-Meyer JE, Chen WC, Lucas CG, Braunstein SE, Oberheim Bush NA, Butowski N, Pekmezci M, McDermott MW, Perry A, Solomon DA, Magill ST, Raleigh DR. Intratumor and informatic heterogeneity influence meningioma molecular classification. Acta Neuropathologica. PMID 35759011 DOI: 10.1007/s00401-022-02455-y |
0.504 |
|
| 2022 |
Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN, Liu SJ, Villanueva-Meyer JE, Lam TC, Pu JK, Li LF, ... ... Raleigh DR, et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nature Genetics. PMID 35534562 DOI: 10.1038/s41588-022-01061-8 |
0.681 |
|
| 2022 |
Chen WC, Lafreniere M, Phuong C, Liu SJ, Baal JD, Lometti M, Morin O, Ziemer B, Vasudevan HN, Lucas CG, Hervey-Jumper SL, Theodosopoulos PV, Magill ST, Fogh S, Nakamura JL, ... ... Raleigh DR, et al. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors. Journal of Neurosurgery. 1-7. PMID 35061986 DOI: 10.3171/2021.10.JNS211886 |
0.544 |
|
| 2021 |
Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, et al. A Molecularly Integrated Grade for Meningioma. Neuro-Oncology. PMID 34508644 DOI: 10.1093/neuonc/noab213 |
0.546 |
|
| 2021 |
Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, Butowski NA. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neuro-Oncology Advances. 3: vdab100. PMID 34466804 DOI: 10.1093/noajnl/vdab100 |
0.358 |
|
| 2021 |
Bush NAO, Young JS, Zhang Y, Dalle Ore CL, Molinaro AM, Taylor J, Clarke J, Prados M, Braunstein SE, Raleigh DR, Chang SM, Berger MS, Butowski NA. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. Journal of Neuro-Oncology. PMID 34125374 DOI: 10.1007/s11060-021-03781-z |
0.358 |
|
| 2021 |
Susko MS, Chen WC, Vasudevan HN, Magill ST, Lucas CG, Oberheim Bush NA, Solomon DA, Theodosopoulos PV, McDermott MW, Villanueva-Meyer JE, Boreta L, Nakamura JL, Sneed PK, Braunstein SE, Raleigh DR. Letter: Patterns of Intermediate- and High-Risk Meningioma Recurrence After Treatment With Postoperative External Beam Radiotherapy. Neurosurgery. PMID 33887769 DOI: 10.1093/neuros/nyab143 |
0.495 |
|
| 2020 |
Lucas CG, Vasudevan HN, Chen WC, Magill ST, Braunstein SE, Jacques L, Dahiya S, Rodriguez FJ, Horvai AE, Perry A, Pekmezci M, Raleigh DR. Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival. Neuro-Oncology Advances. 2: vdaa131. PMID 33880447 DOI: 10.1093/noajnl/vdaa131 |
0.549 |
|
| 2020 |
Haddad AF, Young JS, Kanungo I, Sudhir S, Chen JS, Raleigh DR, Magill ST, McDermott MW, Aghi MK. WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index. Frontiers in Oncology. 10: 1522. PMID 32983999 DOI: 10.3389/Fonc.2020.01522 |
0.602 |
|
| 2020 |
Magill ST, Vasudevan HN, Seo K, Villanueva-Meyer JE, Choudhury A, John Liu S, Pekmezci M, Findakly S, Hilz S, Lastella S, Demaree B, Braunstein SE, Bush NAO, Aghi MK, Theodosopoulos PV, ... ... Raleigh DR, et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nature Communications. 11: 4803. PMID 32968068 DOI: 10.1038/s41467-020-18582-7 |
0.678 |
|
| 2020 |
Chen WC, Vasudevan HN, Choudhury A, Pekmezci M, Lucas CG, Phillips J, Magill ST, Susko MS, Braunstein SE, Oberheim Bush NA, Boreta L, Nakamura JL, Villanueva-Meyer JE, Sneed PK, Perry A, ... ... Raleigh DR, et al. A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection. Neurosurgery. PMID 32860417 DOI: 10.1093/Neuros/Nyaa355 |
0.574 |
|
| 2020 |
Prager BC, Vasudevan HN, Dixit D, Bernatchez JA, Wu Q, Wallace LC, Bhargava S, Lee D, King BH, Morton AR, Gimple RC, Pekmezci M, Zhu Z, Siqueira-Neto JL, Wang X, ... ... Raleigh DR, et al. The Meningioma Enhancer Landscape Delineates Novel Subgroups and Drives Druggable Dependencies. Cancer Discovery. PMID 32703768 DOI: 10.1158/2159-8290.Cd-20-0160 |
0.396 |
|
| 2020 |
Findakly S, Choudhury A, Daggubati V, Pekmezci M, Lang UE, Raleigh DR. Meningioma cells express primary cilia but do not transduce ciliary Hedgehog signals. Acta Neuropathologica Communications. 8: 114. PMID 32690089 DOI: 10.1186/S40478-020-00994-7 |
0.343 |
|
| 2020 |
Choudhury A, Raleigh DR. Preclinical models of meningioma: Cell culture and animal systems. Handbook of Clinical Neurology. 169: 131-136. PMID 32553284 DOI: 10.1016/B978-0-12-804280-9.00008-1 |
0.32 |
|
| 2020 |
Vasudevan HN, Castro MRH, Lee JC, Villanueva-Meyer JE, Bush NAO, McDermott MW, Solomon DA, Perry A, Magill ST, Raleigh DR. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma. Acta Neuropathologica Communications. 8: 82. PMID 32517746 DOI: 10.1186/S40478-020-00952-3 |
0.582 |
|
| 2020 |
Liu SJ, Malatesta M, Lien BV, Saha P, Thombare SS, Hong SJ, Pedraza L, Koontz M, Seo K, Horlbeck MA, He D, Birk HS, Jain M, Olsen HE, Akeson M, ... ... Raleigh DR, et al. CRISPRi-based radiation modifier screen identifies long non-coding RNA therapeutic targets in glioma. Genome Biology. 21: 83. PMID 32234056 DOI: 10.1186/S13059-020-01995-4 |
0.308 |
|
| 2020 |
Liu SJ, Magill ST, Vasudevan HN, Hilz S, Villanueva-Meyer JE, Lastella S, Daggubati V, Spatz J, Choudhury A, Orr BA, Demaree B, Seo K, Ferris SP, Abate AR, Oberheim Bush NA, ... ... Raleigh DR, et al. Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma. Cell Reports. 30: 1300-1309.e5. PMID 32023450 DOI: 10.1016/J.Celrep.2020.01.018 |
0.637 |
|
| 2020 |
Bhaduri A, Di Lullo E, Jung D, Müller S, Crouch EE, Espinosa CS, Ozawa T, Alvarado B, Spatazza J, Cadwell CR, Wilkins G, Velmeshev D, Liu SJ, Malatesta M, Andrews MG, ... ... Raleigh DR, et al. Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma. Cell Stem Cell. 26: 48-63.e6. PMID 31901251 DOI: 10.1016/J.Stem.2019.11.015 |
0.347 |
|
| 2019 |
Morin O, Chen WC, Nassiri F, Susko M, Magill ST, Vasudevan HN, Wu A, Vallières M, Gennatas ED, Valdes G, Pekmezci M, Alcaide-Leon P, Choudhury A, Interian Y, Mortezavi S, ... ... Raleigh DR, et al. Integrated models incorporating radiologic and radiomic features predict meningioma grade, local failure, and overall survival. Neuro-Oncology Advances. 1: vdz011. PMID 31608329 DOI: 10.1093/noajnl/vdz011 |
0.535 |
|
| 2019 |
Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE. Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival. Neuro-Oncology Practice. 6: 364-374. PMID 31555451 DOI: 10.1093/Nop/Npz017 |
0.314 |
|
| 2019 |
Sloan EA, Cooney T, Oberheim Bush NA, Buerki R, Taylor J, Clarke JL, Torkildson J, Kline C, Reddy A, Mueller S, Banerjee A, Butowski N, Chang S, Mummaneni PV, Chou D, ... ... Raleigh DR, et al. Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. Acta Neuropathologica. PMID 31515627 DOI: 10.1007/S00401-019-02072-2 |
0.375 |
|
| 2019 |
Susko M, Yu Y, Ma L, Nakamura J, Fogh S, Raleigh DR, Golden E, Theodosopoulos PV, McDermott MW, Sneed PK, Braunstein SE. Preoperative Dural Contact and Recurrence Risk After Surgical Cavity Stereotactic Radiosurgery for Brain Metastases: New Evidence in Support of Consensus Guidelines. Advances in Radiation Oncology. 4: 458-465. PMID 31360800 DOI: 10.1016/J.Adro.2019.03.002 |
0.322 |
|
| 2019 |
Dalle Ore CL, Magill ST, Yen AJ, Shahin MN, Lee DS, Lucas CG, Chen WC, Viner JA, Aghi MK, Theodosopoulos PV, Raleigh DR, Villanueva-Meyer JE, McDermott MW. Meningioma metastases: incidence and proposed screening paradigm. Journal of Neurosurgery. 1-9. PMID 30952122 DOI: 10.3171/2019.1.Jns181771 |
0.543 |
|
| 2019 |
Voce DJ, Bernal GM, Wu L, Crawley CD, Zhang W, Mansour NM, Cahill KE, Szymura SJ, Uppal A, Raleigh DR, Spretz R, Nunez L, Larsen G, Khodarev NN, Weichselbaum RR, et al. Temozolomide treatment induces lncRNA MALAT1 in an NF-кB and p53 co-dependent manner in glioblastoma. Cancer Research. PMID 30940658 DOI: 10.1158/0008-5472.Can-18-2170 |
0.302 |
|
| 2019 |
Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS, Thangaraj N, Wendelsdorf K, Samuel D, Kline CN, Banerjee A, Auguste K, Raffel C, Gupta N, Berger M, ... Raleigh DR, et al. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathologica. PMID 30877433 DOI: 10.1007/S00401-019-01990-5 |
0.543 |
|
| 2019 |
Magill ST, Shahin MN, Lucas CG, Yen AJ, Lee DS, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Surgical Outcomes, Complications, and Management Strategies for Foramen Magnum Meningiomas. Journal of Neurological Surgery. Part B, Skull Base. 80: 1-9. PMID 30733894 DOI: 10.1055/S-0038-1654702 |
0.61 |
|
| 2019 |
Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, ... ... Raleigh DR, et al. Advances in multidisciplinary therapy for meningiomas. Neuro-Oncology. 21: i18-i31. PMID 30649489 DOI: 10.1093/Neuonc/Noy136 |
0.355 |
|
| 2019 |
Breshears JD, Liu SJ, Vasudevan H, Pekmezci M, Castro MG, Lang U, Chen W, Choudhury A, Magill ST, Braunstein S, Gopinath C, Nakamura JL, Sneed P, Perry A, McDermott MW, ... ... Raleigh DR, et al. Multiplatform Molecular Profiling of Vestibular Schwannoma Reveals 2 Subgroups of Tumors With Distinct Radiographic Features and a Methylation-Based Predictor of Local Recurrence Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_317 |
0.618 |
|
| 2019 |
Susko M, Vasudevan H, Magill S, Calixto-Hope L, Villanueva-Meyer J, Nakamura J, Ann Oberheim-Bush N, Theodosopoulos P, Solomon D, Braunstein S, Sneed P, McDermott M, Raleigh D. MNGI-04. PATTERNS OF FAILURE AND FACTORS INFLUENCING LOCAL RECURRENCE OF MENINGIOMA TREATED WITH POSTOPERATIVE RADIATION THERAPY Neuro-Oncology. 21: vi140-vi140. DOI: 10.1093/Neuonc/Noz175.586 |
0.608 |
|
| 2019 |
John Liu S, Malatesta M, Seo K, Lien B, Hong S, Koontz M, Raleigh D, Ullian E, Lim D. GENE-39. CRISPRi-BASED RADIATION MODIFIER SCREEN IDENTIFIES LONG NON-CODING RNA THERAPEUTIC TARGETS IN GLIOMA Neuro-Oncology. 21: vi106-vi106. DOI: 10.1093/Neuonc/Noz175.441 |
0.328 |
|
| 2019 |
John Liu S, Vasudevan H, Pekmezci M, Choudhury A, Lien B, Breshears J, Swaney D, Magill S, Lang U, Chen W, Gopinath C, Castro M, Villanueva-Meyer J, Braunstein S, Sneed P, ... ... Raleigh D, et al. GENE-37. VESTIBULAR SCHWANNOMA IS COMPRISED OF NEURAL CREST AND IMMUNE SUBGROUPS Neuro-Oncology. 21: vi105-vi105. DOI: 10.1093/Neuonc/Noz175.439 |
0.665 |
|
| 2019 |
Wen Fan Q, Lorenzana E, Luo X, Lea R, Aksoy O, An Z, Ozawa T, Wassarman D, Shokat K, Aggen J, Smith JAM, Singh M, Butowski N, Raleigh D, Weiss W. DDIS-33. SELECTIVE AND COMPLETE INHIBITION OF mTORC1 BY BI-STERIC mTOR INHIBITORS DRIVES THERAPEUTIC RESPONSE IN GLIOBLASTOMA Neuro-Oncology. 21: vi70-vi70. DOI: 10.1093/Neuonc/Noz175.284 |
0.302 |
|
| 2019 |
Magill S, Vasudevan H, Seo K, John Liu S, Hilz S, Villanueva-Meyer J, Choudhury A, Demaree B, Lim D, Braunstein S, Ann Oberheim-Bush N, Ullian E, Aghi M, Theodosopoulos P, Sneed P, ... ... Raleigh D, et al. TMOD-27. A NEURAL CREST CELL SUBPOPULATION UNDERLIES INTRATUMOR HETEROGENEITY IN MENINGIOMA Neuro-Oncology. 21: vi268-vi268. DOI: 10.1093/Neuonc/Noz175.1126 |
0.697 |
|
| 2019 |
Krishna S, Kakaizada S, Valdivia C, Seo K, Raleigh D, Findlay A, Almeida N, Sudharshan R, Choudhury A, Brang D, Nagarajan S, Berger M, Monje M, Hervey-Jumper S. TMIC-46. GLIOMA-INDUCED SYNAPTOGENESIS IS ENRICHED WITHIN FUNCTIONAL CONNECTIVITY NETWORK HUBS AND INFLUENCES LANGUAGE PROCESSING IN ADULT IDH WT GLIOBLASTOMA Neuro-Oncology. 21: vi257-vi258. DOI: 10.1093/Neuonc/Noz175.1080 |
0.429 |
|
| 2019 |
Liu SJ, Magill S, Vasudevan H, Hilz S, Daggubati V, Villanueva-Meyer J, Choudhury A, Ferris S, Orr B, Bush NAO, Bollen A, McDermott M, Costello J, Raleigh D. EPEN-02. MULTIPLATFORM MOLECULAR PROFILING REVEALS INTRATUMOR HETEROGENEITY IN EPENDYMOMA Neuro-Oncology. 21: ii77-ii78. DOI: 10.1093/Neuonc/Noz036.061 |
0.629 |
|
| 2019 |
Vasudevan H, Lucas C, Liu S, Choudhury A, Magill S, Gopinath C, Nakamura J, Braunstein S, Perry A, Pekmezci M, Raleigh D. Postoperative Radiation Therapy Improves Progression-Free Survival in Malignant Peripheral Nerve Sheath Tumors International Journal of Radiation Oncology*Biology*Physics. 105: E801-E802. DOI: 10.1016/J.Ijrobp.2019.06.2494 |
0.58 |
|
| 2019 |
Liu S, Vasudevan H, Breshears J, Pekmezci M, Villanueva-Meyer J, Lang U, Chen W, Choudhury A, Magill S, Braunstein S, Gopinath C, Nakamura J, Tward A, Sneed P, Perry A, ... ... Raleigh D, et al. Multiplatform Molecular Profiling of Vestibular Schwannoma Reveals Immune Enrichment after Radiosurgery and a Methylation-Based Predictor of Recurrence International Journal of Radiation Oncology*Biology*Physics. 105: E67. DOI: 10.1016/J.Ijrobp.2019.06.2415 |
0.565 |
|
| 2018 |
Fritchie K, Jensch K, Moskalev EA, Caron A, Jenkins S, Link M, Brown PD, Rodriguez FJ, Guajardo A, Brat D, Velázquez Vega JE, Perry A, Wu A, Raleigh DR, Santagata S, et al. The impact of histopathology and NAB2-STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma. Acta Neuropathologica. PMID 30584643 DOI: 10.1007/S00401-018-1952-6 |
0.362 |
|
| 2018 |
Magill ST, Dalle Ore CL, Diaz MA, Jalili DD, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Surgical outcomes after reoperation for recurrent non-skull base meningiomas. Journal of Neurosurgery. 1-9. PMID 30544357 DOI: 10.3171/2018.6.JNS18118 |
0.573 |
|
| 2018 |
Gennatas ED, Wu A, Braunstein SE, Morin O, Chen WC, Magill ST, Gopinath C, Villaneueva-Meyer JE, Perry A, McDermott MW, Solberg TD, Valdes G, Raleigh DR. Preoperative and postoperative prediction of long-term meningioma outcomes. Plos One. 13: e0204161. PMID 30235308 DOI: 10.1371/Journal.Pone.0204161 |
0.584 |
|
| 2018 |
Hara JH, Wu A, Villanueva-Meyer JE, Valdes G, Daggubati V, Mueller S, Solberg TD, Braunstein SE, Morin O, Raleigh DR. Clinical Applications of Quantitative 3-Dimensional MRI Analysis for Pediatric Embryonal Brain Tumors. International Journal of Radiation Oncology, Biology, Physics. PMID 30108003 DOI: 10.1016/J.Ijrobp.2018.05.077 |
0.315 |
|
| 2018 |
Magill ST, Lee DS, Yen AJ, Lucas CG, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Surgical outcomes after reoperation for recurrent skull base meningiomas. Journal of Neurosurgery. 1-8. PMID 29726777 DOI: 10.3171/2017.11.Jns172278 |
0.615 |
|
| 2018 |
Magill ST, Rick JW, Chen WC, Haase DA, Raleigh DR, Aghi MK, Theodosopoulos PV, McDermott MW. Petrous Face Meningiomas: Classification, Clinical Syndromes and Surgical Outcomes. World Neurosurgery. PMID 29626689 DOI: 10.1016/J.Wneu.2018.03.194 |
0.578 |
|
| 2018 |
Chen WC, Magill ST, Wu A, Vasudevan HN, Morin O, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Braunstein SE, Raleigh DR. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy. Journal of Neurosurgery. 1-8. PMID 29624151 DOI: 10.3171/2017.9.Jns171609 |
0.581 |
|
| 2018 |
Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, Reis GF, Magill ST, Zhang J, Feng FY, Nicholaides T, Chang SM, Sneed PK, McDermott MW, Berger MS, ... ... Raleigh DR, et al. Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation. Cell Reports. 22: 3672-3683. PMID 29590631 DOI: 10.1016/J.Celrep.2018.03.013 |
0.663 |
|
| 2018 |
Chen WC, Hara J, Magill ST, Wu A, Aghi MK, Theodosopoulos PV, Perry A, McDermott MW, Sneed PK, Raleigh DR, Braunstein SE. Salvage therapy outcomes for atypical meningioma. Journal of Neuro-Oncology. PMID 29480505 DOI: 10.1007/S11060-018-2813-9 |
0.612 |
|
| 2018 |
Raleigh DR, Choksi PK, Krup AL, Mayer W, Santos N, Reiter JF. Hedgehog signaling drives medulloblastoma growth via CDK6. The Journal of Clinical Investigation. 128: 120-124. PMID 29202464 DOI: 10.1172/Jci92710 |
0.307 |
|
| 2018 |
Fritchie K, Jensch K, Jenkins S, Link M, D Brown P, Rodriguez F, Guajardo A, Brat D, Velazquez Vega J, Perry A, Wu A, Raleigh D, Santagata S, Louis D, Brastianos P, et al. RARE-08. GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA Neuro-Oncology. 20: vi237-vi238. DOI: 10.1093/Neuonc/Noy148.985 |
0.338 |
|
| 2018 |
Chapman C, Hara J, Clarke J, Butowski N, Chang S, Fogh S, Sneed P, Nakamura J, Raleigh D, Braunstein S. Rthp-11. Reirradiation Of Recurrent High Grade Gliomas: Outcomes And Prognostic Factors Neuro-Oncology. 20. DOI: 10.1093/Neuonc/Noy148.943 |
0.324 |
|
| 2018 |
Hara J, Wu A, Villanueva-Meyer J, Valdes G, Daggubati V, Mueller S, Solberg T, Braunstein S, Morin O, Raleigh D. NIMG-67. CLINICAL APPLICATIONS OF QUANTITATIVE THREE-DIMENSIONAL MRI ANALYSIS FOR PEDIATRIC EMBRYONAL BRAIN TUMORS Neuro-Oncology. 20: vi191-vi191. DOI: 10.1093/Neuonc/Noy148.791 |
0.304 |
|
| 2018 |
Chen W, Lucas C, Baal J, Magill S, Wu A, Hara J, Morin O, Gopinath C, Braunstein S, Oberheim Bush NA, McDermott M, Perry A, Solomon D, Villanueva-Meyer J, Raleigh D. MNGI-30. RADIOLOGIC FEATURES ARE PROGNOSTIC FOR CLINICAL OUTCOMES OF CHORDOID MENINGIOMA Neuro-Oncology. 20: vi155-vi155. DOI: 10.1093/Neuonc/Noy148.646 |
0.557 |
|
| 2018 |
Morin O, Chen W, Gennatas E, Magill S, Wu A, Valdes G, Perry A, Sneed P, McDermott M, Solberg T, Bush NAO, Braunstein S, Villanueva-Meyer J, Raleigh D. MNGI-23. PREOPERATIVE QUANTITATIVE IMAGING FEATURES ARE PROGNOSTIC FOR MENINGIOMA OUTCOMES Neuro-Oncology. 20: vi153-vi154. DOI: 10.1093/Neuonc/Noy148.639 |
0.56 |
|
| 2018 |
Dalle Ore C, Magill S, Yen A, Shahin M, Lee D, Lucas C, Viner J, Aghi M, Theodosopoulos P, Raleigh D, Villanueva-Meyer J, McDermott M. MNGI-06. MENINGIOMA METASTASES: INCIDENCE AND SCREENING IN 1203 PATIENTS Neuro-Oncology. 20: vi149-vi149. DOI: 10.1093/Neuonc/Noy148.622 |
0.522 |
|
| 2018 |
Villanueva-Meyer J, Magill S, Probst K, Bush NAO, Raleigh D, Theodosopoulos P, Aghi M, McDermott M. MNGI-04. A PROPOSED IMAGING-BASED NOMENCLATURE SYSTEM FOR MENINGIOMAS Neuro-Oncology. 20: vi148-vi148. DOI: 10.1093/Neuonc/Noy148.620 |
0.518 |
|
| 2018 |
Magill S, Liu J, Vasudevan H, Hilz S, Ferris S, Ann N, Bush O, Villanueva-Meyer J, Bollen A, Costello J, McDermott M, Raleigh D. GENE-31. MULTIPLATFORM MOLECULAR PROFILING AND QUANTITATIVE IMAGING OF AN ANAPLASTIC EPENDYMOMA REVEALS INTRATUMORAL HETEROGENEITY Neuro-Oncology. 20: vi110-vi110. DOI: 10.1093/Neuonc/Noy148.457 |
0.625 |
|
| 2018 |
Morin O, Chen W, Villanueva-Meyer J, Gennatas E, Wu A, Cha S, Magill S, Perry A, Sneed P, McDermott M, Solberg T, Valdes G, Braunstein S, Raleigh D. Point-of-Care Local Failure and Overall Survival Prediction Models for Meningioma International Journal of Radiation Oncology*Biology*Physics. 102: e306-e307. DOI: 10.1016/J.Ijrobp.2018.07.962 |
0.537 |
|
| 2018 |
Chen W, Hara J, Magill S, Wu A, Aghi M, Theodosopoulos P, Perry A, McDermott M, Sneed P, Braunstein S, Raleigh D. Clinical Outcomes and Safety Profile of Salvage External Beam Radiation Therapy and Re-Irradiation for Recurrent Atypical Meningioma International Journal of Radiation Oncology*Biology*Physics. 102: e210. DOI: 10.1016/J.Ijrobp.2018.07.736 |
0.559 |
|
| 2018 |
Chapman CH, Hara J, Clarke J, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh D, Braunstein SE. Reirradiation of Recurrent High Grade Gliomas: Outcomes and Prognostic Factors International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.732 |
0.324 |
|
| 2018 |
Gennatas E, Wu A, Braunstein S, Morin O, Chen W, Magill S, Villanueva-Meyer J, Perry A, McDermott M, Solberg T, Valdes G, Raleigh D. Pre- and Postoperative Prediction of Long-Term Meningioma Outcomes International Journal of Radiation Oncology*Biology*Physics. 102: e198-e199. DOI: 10.1016/J.Ijrobp.2018.07.709 |
0.544 |
|
| 2017 |
Kline CN, Packer RJ, Hwang EI, Raleigh DR, Braunstein S, Raffel C, Bandopadhayay P, Solomon DA, Aboian M, Cha S, Mueller S. Case-based review: pediatric medulloblastoma. Neuro-Oncology Practice. 4: 138-150. PMID 29692919 DOI: 10.1093/Nop/Npx011 |
0.376 |
|
| 2017 |
Wu A, Garcia MA, Magill ST, Chen W, Vasudevan HN, Perry A, Theodosopoulos PV, McDermott MW, Braunstein SE, Raleigh DR. Presenting symptoms and prognostic factors for symptomatic outcomes following resection of meningioma. World Neurosurgery. PMID 29248774 DOI: 10.1016/J.Wneu.2017.12.012 |
0.579 |
|
| 2017 |
Chen W, Magill S, Wu A, Vasudevan H, Aghi M, Theodosopoulos P, Perry A, McDermott M, Sneed P, Braunstein S, Raleigh D. MNGI-09. HISTOPATHOLOGIC FEATURES PREDICT LOCAL CONTROL AFTER ADJUVANT RADIOTHERAPY FOR ATYPICAL MENINGIOMA Neuro-Oncology. 19: vi133-vi134. DOI: 10.1093/Neuonc/Nox168.547 |
0.552 |
|
| 2017 |
Vasudevan H, Braunstein S, Phillips JJ, Pekmezci M, Wu A, Reis G, Magill S, Chang S, Sneed P, McDermott M, Perry A, Raleigh D. GENE-04. COMPREHENSIVE GENOMIC CHARACTERIZATION OF AGGRESSIVE MENINGIOMAS IDENTIFIES MOLECULAR SIGNATURES THAT PREDICT CLINICAL OUTCOMES Neuro-Oncology. 19: vi92-vi93. DOI: 10.1093/Neuonc/Nox168.379 |
0.57 |
|
| 2017 |
Vasudevan H, Braunstein S, Wu A, Reis G, Magill S, Phillips J, Chang S, Sneed P, McDermott M, Perry A, Raleigh D. Molecular Profiling of Meningioma Identifies Genomic Signatures That Predict Clinical Outcomes Independent of Tumor Grade International Journal of Radiation Oncology*Biology*Physics. 99: S22. DOI: 10.1016/J.Ijrobp.2017.06.064 |
0.605 |
|
| 2016 |
Raleigh DR, Tomlin B, Buono BD, Roddy E, Sear K, Byer L, Felton E, Banerjee A, Torkildson J, Samuel D, Horn B, Braunstein SE, Haas-Kogan DA, Mueller S. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients. Journal of Neuro-Oncology. PMID 27778212 DOI: 10.1016/J.Ijrobp.2017.02.198 |
0.346 |
|
| 2016 |
Raleigh DR, Seymour ZA, Tomlin B, Theodosopoulos PV, Berger MS, Aghi MK, Geneser SE, Krishnamurthy D, Fogh SE, Sneed PK, McDermott MW. Resection and brain brachytherapy with permanent iodine-125 sources for brain metastasis. Journal of Neurosurgery. 1-7. PMID 27367240 DOI: 10.3171/2016.4.Jns152530 |
0.459 |
|
| 2016 |
Raleigh DR, Solomon DA, Lloyd SA, Lazar A, Garcia MA, Sneed PK, Clarke JL, McDermott MW, Berger MS, Tihan T, Haas-Kogan DA. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro-Oncology. PMID 27282397 DOI: 10.1093/Neuonc/Now105 |
0.486 |
|
| 2016 |
Magill ST, Lau D, Raleigh DR, Sneed PK, Fogh SE, McDermott MW. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series. Neurosurgery. PMID 27258768 DOI: 10.1227/Neu.0000000000001262 |
0.579 |
|
| 2016 |
Kaprealian T, Raleigh DR, Sneed PK, Nabavizadeh N, Nakamura JL, McDermott MW. Parameters influencing local control of meningiomas treated with radiosurgery. Journal of Neuro-Oncology. PMID 27131883 DOI: 10.1007/S11060-016-2121-1 |
0.383 |
|
| 2016 |
Vaubel RA, Chen SG, Raleigh DR, Link MJ, Chicoine MR, Barani I, Jenkins SM, Aleff PA, Rodriguez FJ, Burger PC, Dahiya S, Perry A, Giannini C. Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature. Journal of Neuropathology and Experimental Neurology. 75: 44-52. PMID 26705409 DOI: 10.1093/Jnen/Nlv006 |
0.374 |
|
| 2015 |
Menke JR, Raleigh DR, Gown AM, Thomas S, Perry A, Tihan T. Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen. Acta Neuropathologica. 130: 441-3. PMID 26195322 DOI: 10.1007/S00401-015-1459-3 |
0.307 |
|
| 2015 |
Raleigh DR, Algazi A, Arron ST, Neuhaus IM, Yom SS. Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma. The British Journal of Dermatology. 173: 544-6. PMID 25702621 DOI: 10.1111/Bjd.13748 |
0.313 |
|
| 2015 |
Barani IJ, Raleigh DR, Larson D. The management of central neurocytoma: radiotherapy. Neurosurgery Clinics of North America. 26: 45-56. PMID 25432183 DOI: 10.1016/J.Nec.2014.09.014 |
0.374 |
|
| 2015 |
Raleigh D, Lloyd S, Solomon D, Lazar A, Tihan T, Sneed P, Clarke J, Varenika V, Garcia M, Muller S, Berger M, Haas-Kogan D. Outcomes and Prognostic Factors for Pineal Parenchymal Tumors: A 25 Year Single-Institution Experience International Journal of Radiation Oncology*Biology*Physics. 93: E63. DOI: 10.1016/J.Ijrobp.2015.07.704 |
0.495 |
|
| 2015 |
Garcia M, Raleigh D, Maghsoudi K, Braunstein S, Clarke J, Sneed P, Fogh S, Larson D, Nakamura J, Barani I, Mueller S, Berger M, Haas-Kogan D. Outcomes and Salvage Therapy for Recurrent Choroid Plexus Tumors: A 25-Year Single-Institution Experience International Journal of Radiation Oncology*Biology*Physics. 93: E504. DOI: 10.1016/J.Ijrobp.2015.07.1835 |
0.475 |
|
| 2014 |
Raleigh DR, Haas-Kogan DA. Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response. Frontiers in Oncology. 4: 228. PMID 25202680 DOI: 10.3389/Fonc.2014.00228 |
0.372 |
|
| 2014 |
Chang AJ, Roach M, Gottschalk A, Cunha AJ, Seymour ZA, Johnson JA, Raleigh D, Shinohara K, Hsu IJ. Long-Term Outcomes of Patients With High-Risk Prostate Cancer Treated With HDR Brachytherapy Boost International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1406 |
0.31 |
|
| 2013 |
Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, Breskin LA, Wu L, Anderson K, Turner JR, Weber CR. Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Molecular Biology of the Cell. 24: 3056-68. PMID 23924897 DOI: 10.1091/Mbc.E12-09-0688 |
0.584 |
|
| 2011 |
Raleigh DR, Boe DM, Yu D, Weber CR, Marchiando AM, Bradford EM, Wang Y, Wu L, Schneeberger EE, Shen L, Turner JR. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. The Journal of Cell Biology. 193: 565-82. PMID 21536752 DOI: 10.1083/Jcb.201010065 |
0.756 |
|
| 2011 |
Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. Tight junction pore and leak pathways: a dynamic duo. Annual Review of Physiology. 73: 283-309. PMID 20936941 DOI: 10.1146/annurev-physiol-012110-142150 |
0.614 |
|
| 2010 |
Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proceedings of the National Academy of Sciences of the United States of America. 107: 8237-41. PMID 20404178 DOI: 10.1073/Pnas.0908869107 |
0.76 |
|
| 2010 |
Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR, Raleigh DR, Guan Y, Watson AJ, Montrose MH, Turner JR. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. The Journal of Cell Biology. 189: 111-26. PMID 20351069 DOI: 10.1083/Jcb.200902153 |
0.759 |
|
| 2010 |
Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. The Journal of Biological Chemistry. 285: 12037-46. PMID 20177070 DOI: 10.1074/Jbc.M109.064808 |
0.592 |
|
| 2010 |
Raleigh DR, Marchiando AM, Zhang Y, Shen L, Sasaki H, Wang Y, Long M, Turner JR. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Molecular Biology of the Cell. 21: 1200-13. PMID 20164257 DOI: 10.1091/Mbc.E09-08-0734 |
0.761 |
|
| 2009 |
Weber CR, Raleigh DR, Wang Y, Turner JR. T1725 Interleukin 13 (IL-13) and Tumor Necrosis Factor (TNF) Affect Distinct Components of the Tight Junction Barrier By Differing Mechanisms Gastroenterology. 136: A-566-A-567. DOI: 10.1016/S0016-5085(09)62606-8 |
0.463 |
|
| 2009 |
Raleigh DR, Zhang Y, Marchiando AM, Wang Y, Shen L, Long M, Turner JR. S1757 TAMPs: A Tight Junction Protein Family with Non-Redundant Functions Gastroenterology. 136: A-264. DOI: 10.1016/S0016-5085(09)61201-4 |
0.745 |
|
| Show low-probability matches. |